The underlying cause of congenital supravalvular aortic stenosis (SVAS) has
recently been identified as a loss-of function mutation of the elastin gen
e on chromosome 7q11.23, resulting in an obstructive arteriopathy of varyin
g severity, which is most prominent at the aortic sinutubular junction. The
generalized nature of the disease explains the frequent association with s
tenoses of systemic and pulmonary arteries. Furthermore, localization of th
e supravalvular stenosis at the level of the commissures of the aortic valv
e has important implications for both aortic valve function and coronary ci
rculation. This review summarizes the recent advances with regard to the pa
thogenesis of SVAS and describes the multitude of clinically relevant patho
logic features other that the men 'supra-aortic' narrowing that have import
ant implications for surgical therapy. (C) 2001 Elsevier Science B.V, All r
ights reserved.